What is the mechanism of action of this treatment?

Common treatments for stuttering, particularly those involving speech-language pathology and telehealth, focus on improving fluency by addressing speech, language, and psychosocial factors. These treatments often include techniques such as controlled fluency shaping, which helps patients develop smoother speech patterns, and stuttering modification, which aims to reduce the severity and frequency of stuttering episodes. Additionally, cognitive-behavioral therapy (CBT) is used to address the anxiety and negative emotions associated with stuttering. The use of telehealth allows for greater accessibility and consistency in treatment, which is crucial for sustained improvement. These mechanisms are important for stuttering patients as they not only improve speech fluency but also enhance overall communication skills and reduce the psychological burden of stuttering.

What side effects are associated with this type of intervention?

Common treatments for stuttering, particularly those involving speech-language pathology and telehealth, focus on improving fluency by addressing speech, language, and psychosocial factors. These treatments generally have minimal physical side effects. However, patients may experience emotional and psychological challenges, such as frustration or anxiety, especially during the initial stages of therapy. Additionally, the effectiveness of telehealth interventions can be influenced by the patient's comfort with technology and the quality of the internet connection, which may cause stress or hinder progress.

What prior FDA approvals exist?

There are no specific FDA-approved medications for the treatment of stuttering. Current treatment approaches primarily involve speech-language pathology techniques, which may include fluency shaping, stuttering modification, and addressing psychosocial factors. These methods can be delivered through traditional in-person sessions or via telehealth platforms, as studied in recent trials. The focus remains on improving speech fluency and managing the emotional and social impacts of stuttering.

What other types of research exist?

Promising novel alternatives to SLP treatment via telehealth for stuttering patients include interdisciplinary approaches combining speech therapy with psychological support, digital CBT-I (Cognitive Behavioral Therapy for Insomnia) to address anxiety-related speech issues, and the use of mobile apps for real-time feedback and practice. These methods leverage technology and holistic care to improve fluency and overall communication skills.

← Back to Search

CARE Model Therapy for Stuttering

N/A

Recruiting

Led By Courtney T Byrd, PhD

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 11-weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing online therapy sessions and specialized training for speech therapists to help people who stutter. It focuses on both monolingual and multilingual speakers. The goal is to improve their speech fluency by addressing various factors like speech patterns, language skills, and psychological aspects.

Who is the study for?

This trial is for children (2-17 years) and adults (18+ years) who stutter. Eligible participants are those recognized by caregivers or self-reported as individuals who stutter, have been diagnosed by a speech-language pathologist, or show a certain level of disfluency in their speech.

What is being tested?

The study is examining the Blank Center CARE Model(TM), focusing on how it can help people who stutter. It looks at contributions to stuttering and evaluates telehealth treatments and training methods for fluency disorders.

What are the potential side effects?

Since this trial involves non-medical interventions like speech therapy, there aren't typical medical side effects; however, participants may experience fatigue or frustration during treatment sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 11-weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~11-weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 11-weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Advocacy

Communication Competence

Education

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Blank Center CARE Model (Communication, Advocacy, Resilience, Education)Experimental Treatment1 Intervention

Do I qualify?Apply below to find out

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Common treatments for stuttering, particularly those involving speech-language pathology and telehealth, focus on improving fluency by addressing speech, language, and psychosocial factors. These treatments often include techniques such as controlled fluency shaping, which helps patients develop smoother speech patterns, and stuttering modification, which aims to reduce the severity and frequency of stuttering episodes. Additionally, cognitive-behavioral therapy (CBT) is used to address the anxiety and negative emotions associated with stuttering. The use of telehealth allows for greater accessibility and consistency in treatment, which is crucial for sustained improvement. These mechanisms are important for stuttering patients as they not only improve speech fluency but also enhance overall communication skills and reduce the psychological burden of stuttering.